Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2144460602', 'doi': 'https://doi.org/10.1517/13543784.10.4.593', 'title': 'β-Amyloid therapies in Alzheimer’s disease', 'display_name': 'β-Amyloid therapies in Alzheimer’s disease', 'publication_year': 2001, 'publication_date': '2001-04-01', 'ids': {'openalex': 'https://openalex.org/W2144460602', 'doi': 'https://doi.org/10.1517/13543784.10.4.593', 'mag': '2144460602', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/11281811'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/13543784.10.4.593', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S131064935', 'display_name': 'Expert Opinion on Investigational Drugs', 'issn_l': '1354-3784', 'issn': ['1354-3784', '1744-7658'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5059074751', 'display_name': 'Stanford Jhee', 'orcid': 'https://orcid.org/0000-0002-0784-6522'}, 'institutions': [{'id': 'https://openalex.org/I4210142143', 'display_name': 'Los Angeles Clinical Trials', 'ror': 'https://ror.org/04eme8h94', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210142143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Stanford Jhee', 'raw_affiliation_strings': ['California Clinical Trials/Ingenix Pharmaceutical Services, 8501 Wilshire Blvd, Beverly Hills, CA 90211, USA. [email protected]'], 'affiliations': [{'raw_affiliation_string': 'California Clinical Trials/Ingenix Pharmaceutical Services, 8501 Wilshire Blvd, Beverly Hills, CA 90211, USA. [email protected]', 'institution_ids': ['https://openalex.org/I4210142143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059906325', 'display_name': 'Thomas Shiovitz', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142143', 'display_name': 'Los Angeles Clinical Trials', 'ror': 'https://ror.org/04eme8h94', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210142143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Thomas Shiovitz', 'raw_affiliation_strings': ['California Clinical Trials/Ingenix Pharmaceutical Services, 8501 Wilshire Blvd, Beverly Hills, CA 90211, USA. [email protected]'], 'affiliations': [{'raw_affiliation_string': 'California Clinical Trials/Ingenix Pharmaceutical Services, 8501 Wilshire Blvd, Beverly Hills, CA 90211, USA. [email protected]', 'institution_ids': ['https://openalex.org/I4210142143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5084341206', 'display_name': 'Aaron W. Crawford', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142143', 'display_name': 'Los Angeles Clinical Trials', 'ror': 'https://ror.org/04eme8h94', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210142143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Aaron W Crawford', 'raw_affiliation_strings': ['California Clinical Trials/Ingenix Pharmaceutical Services, 8501 Wilshire Blvd, Beverly Hills, CA 90211, USA. [email protected]'], 'affiliations': [{'raw_affiliation_string': 'California Clinical Trials/Ingenix Pharmaceutical Services, 8501 Wilshire Blvd, Beverly Hills, CA 90211, USA. [email protected]', 'institution_ids': ['https://openalex.org/I4210142143']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5070455767', 'display_name': 'Neal R. Cutler', 'orcid': 'https://orcid.org/0000-0002-0639-2266'}, 'institutions': [{'id': 'https://openalex.org/I4210142143', 'display_name': 'Los Angeles Clinical Trials', 'ror': 'https://ror.org/04eme8h94', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210142143']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Neal R Cutler', 'raw_affiliation_strings': ['California Clinical Trials/Ingenix Pharmaceutical Services, 8501 Wilshire Blvd, Beverly Hills, CA 90211, USA. [email protected]'], 'affiliations': [{'raw_affiliation_string': 'California Clinical Trials/Ingenix Pharmaceutical Services, 8501 Wilshire Blvd, Beverly Hills, CA 90211, USA. [email protected]', 'institution_ids': ['https://openalex.org/I4210142143']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.573, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 24, 'citation_normalized_percentile': {'value': 0.374835, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 86, 'max': 87}, 'biblio': {'volume': '10', 'issue': '4', 'first_page': '593', 'last_page': '605'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10086', 'display_name': "Mechanisms of Alzheimer's Disease", 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10086', 'display_name': "Mechanisms of Alzheimer's Disease", 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12023', 'display_name': 'Cholinesterase Inhibitors in Neurodegenerative Diseases', 'score': 0.9965, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11335', 'display_name': 'Prion Diseases: Causes and Molecular Basis', 'score': 0.9911, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/beta', 'display_name': 'BETA (programming language)', 'score': 0.6119743}, {'id': 'https://openalex.org/keywords/amyloid-beta', 'display_name': 'Amyloid beta', 'score': 0.5877793}, {'id': 'https://openalex.org/keywords/amyloid', 'display_name': 'Amyloid (mycology)', 'score': 0.5544132}, {'id': 'https://openalex.org/keywords/p3-peptide', 'display_name': 'P3 peptide', 'score': 0.5210518}, {'id': "https://openalex.org/keywords/alzheimer's-disease", 'display_name': "Alzheimer's Disease", 'score': 0.481262}, {'id': 'https://openalex.org/keywords/alpha-secretase', 'display_name': 'Alpha secretase', 'score': 0.431252}, {'id': 'https://openalex.org/keywords/tau-protein', 'display_name': 'Tau protein', 'score': 0.42471838}, {'id': 'https://openalex.org/keywords/bace1-as', 'display_name': 'BACE1-AS', 'score': 0.41888657}], 'concepts': [{'id': 'https://openalex.org/C68026918', 'wikidata': 'https://www.wikidata.org/wiki/Q1970256', 'display_name': 'Senile plaques', 'level': 4, 'score': 0.7358884}, {'id': 'https://openalex.org/C31705614', 'wikidata': 'https://www.wikidata.org/wiki/Q423510', 'display_name': 'Amyloid precursor protein', 'level': 4, 'score': 0.68369055}, {'id': 'https://openalex.org/C2776174256', 'wikidata': 'https://www.wikidata.org/wiki/Q830842', 'display_name': 'BETA (programming language)', 'level': 2, 'score': 0.6119743}, {'id': 'https://openalex.org/C2776156579', 'wikidata': 'https://www.wikidata.org/wiki/Q417667', 'display_name': 'Amyloid beta', 'level': 3, 'score': 0.5877793}, {'id': 'https://openalex.org/C180081513', 'wikidata': 'https://www.wikidata.org/wiki/Q4914721', 'display_name': "Biochemistry of Alzheimer's disease", 'level': 5, 'score': 0.5852831}, {'id': 'https://openalex.org/C182220744', 'wikidata': 'https://www.wikidata.org/wiki/Q7251226', 'display_name': 'Proteases', 'level': 3, 'score': 0.57118297}, {'id': 'https://openalex.org/C2777633098', 'wikidata': 'https://www.wikidata.org/wiki/Q2736051', 'display_name': 'Amyloid (mycology)', 'level': 2, 'score': 0.5544132}, {'id': 'https://openalex.org/C36103677', 'wikidata': 'https://www.wikidata.org/wiki/Q4749551', 'display_name': 'Amyloid precursor protein secretase', 'level': 5, 'score': 0.5385716}, {'id': 'https://openalex.org/C177907266', 'wikidata': 'https://www.wikidata.org/wiki/Q17155455', 'display_name': 'P3 peptide', 'level': 5, 'score': 0.5210518}, {'id': 'https://openalex.org/C502032728', 'wikidata': 'https://www.wikidata.org/wiki/Q11081', 'display_name': "Alzheimer's disease", 'level': 3, 'score': 0.492099}, {'id': 'https://openalex.org/C28406088', 'wikidata': 'https://www.wikidata.org/wiki/Q5571762', 'display_name': 'Extracellular', 'level': 2, 'score': 0.4867337}, {'id': 'https://openalex.org/C169760540', 'wikidata': 'https://www.wikidata.org/wiki/Q207011', 'display_name': 'Neuroscience', 'level': 1, 'score': 0.47668576}, {'id': 'https://openalex.org/C41007966', 'wikidata': 'https://www.wikidata.org/wiki/Q908080', 'display_name': 'Alpha secretase', 'level': 5, 'score': 0.431252}, {'id': 'https://openalex.org/C2778670691', 'wikidata': 'https://www.wikidata.org/wiki/Q419507', 'display_name': 'Tau protein', 'level': 4, 'score': 0.42471838}, {'id': 'https://openalex.org/C151484617', 'wikidata': 'https://www.wikidata.org/wiki/Q4834493', 'display_name': 'BACE1-AS', 'level': 5, 'score': 0.41888657}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.38677388}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.3741333}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.37307984}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.3703524}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.34211722}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.29867172}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.29214013}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.22924644}, {'id': 'https://openalex.org/C41008148', 'wikidata': 'https://www.wikidata.org/wiki/Q21198', 'display_name': 'Computer science', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C199360897', 'wikidata': 'https://www.wikidata.org/wiki/Q9143', 'display_name': 'Programming language', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000544', 'descriptor_name': 'Alzheimer Disease', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D016229', 'descriptor_name': 'Amyloid beta-Peptides', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D010450', 'descriptor_name': 'Endopeptidases', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': True}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000544', 'descriptor_name': 'Alzheimer Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000595', 'descriptor_name': 'Amino Acid Sequence', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D053829', 'descriptor_name': 'Amyloid Precursor Protein Secretases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016229', 'descriptor_name': 'Amyloid beta-Peptides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016229', 'descriptor_name': 'Amyloid beta-Peptides', 'qualifier_ui': 'Q000096', 'qualifier_name': 'biosynthesis', 'is_major_topic': False}, {'descriptor_ui': 'D016282', 'descriptor_name': 'Aspartic Acid Endopeptidases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016282', 'descriptor_name': 'Aspartic Acid Endopeptidases', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D010450', 'descriptor_name': 'Endopeptidases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008969', 'descriptor_name': 'Molecular Sequence Data', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/13543784.10.4.593', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S131064935', 'display_name': 'Expert Opinion on Investigational Drugs', 'issn_l': '1354-3784', 'issn': ['1354-3784', '1744-7658'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/11281811', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.57}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 70, 'referenced_works': ['https://openalex.org/W1480987708', 'https://openalex.org/W1516600697', 'https://openalex.org/W1531666134', 'https://openalex.org/W1554018543', 'https://openalex.org/W1567490604', 'https://openalex.org/W1595935608', 'https://openalex.org/W1644122431', 'https://openalex.org/W1655397332', 'https://openalex.org/W1655404681', 'https://openalex.org/W1675105744', 'https://openalex.org/W1693283493', 'https://openalex.org/W1754645121', 'https://openalex.org/W1762207349', 'https://openalex.org/W1945588738', 'https://openalex.org/W1964746966', 'https://openalex.org/W1967237003', 'https://openalex.org/W1971256323', 'https://openalex.org/W1975775468', 'https://openalex.org/W1976722719', 'https://openalex.org/W1979240613', 'https://openalex.org/W1979432217', 'https://openalex.org/W1979543098', 'https://openalex.org/W1980354471', 'https://openalex.org/W1984220376', 'https://openalex.org/W1984752460', 'https://openalex.org/W1987452659', 'https://openalex.org/W1988602805', 'https://openalex.org/W1990543766', 'https://openalex.org/W1991435932', 'https://openalex.org/W1995434077', 'https://openalex.org/W2000706612', 'https://openalex.org/W2001870435', 'https://openalex.org/W2001914338', 'https://openalex.org/W2012426951', 'https://openalex.org/W2017643275', 'https://openalex.org/W2022768979', 'https://openalex.org/W2023531011', 'https://openalex.org/W2032665239', 'https://openalex.org/W2033382511', 'https://openalex.org/W2033847972', 'https://openalex.org/W2037288419', 'https://openalex.org/W2038421461', 'https://openalex.org/W2039716280', 'https://openalex.org/W2040550699', 'https://openalex.org/W2045153164', 'https://openalex.org/W2046209489', 'https://openalex.org/W2048975745', 'https://openalex.org/W2051651977', 'https://openalex.org/W2059214757', 'https://openalex.org/W2062283435', 'https://openalex.org/W2067199737', 'https://openalex.org/W2071310220', 'https://openalex.org/W2075175573', 'https://openalex.org/W2075735990', 'https://openalex.org/W2075814487', 'https://openalex.org/W2081881251', 'https://openalex.org/W2083633251', 'https://openalex.org/W2084399566', 'https://openalex.org/W2086327508', 'https://openalex.org/W2097773756', 'https://openalex.org/W2122795651', 'https://openalex.org/W2133019124', 'https://openalex.org/W2138416159', 'https://openalex.org/W2140503956', 'https://openalex.org/W2156910937', 'https://openalex.org/W2162815565', 'https://openalex.org/W2163893226', 'https://openalex.org/W2426397924', 'https://openalex.org/W2775777157', 'https://openalex.org/W4240505437'], 'related_works': ['https://openalex.org/W2607241233', 'https://openalex.org/W2394822779', 'https://openalex.org/W2139018071', 'https://openalex.org/W2128852790', 'https://openalex.org/W2072303926', 'https://openalex.org/W2026432301', 'https://openalex.org/W2005967565', 'https://openalex.org/W1606577628', 'https://openalex.org/W1578243658', 'https://openalex.org/W130541234'], 'abstract_inverted_index': {'Neurones': [0], 'in': [1, 29, 67, 166], 'the': [2, 14, 22, 36, 49, 55, 68, 76, 83, 89, 108, 142, 160], 'brain': [3], 'produce': [4], 'β-amyloid': [5], '(Aβ)': [6], 'fragments': [7, 26, 45], 'from': [8, 21], 'a': [9], 'larger': [10], 'precursor': [11, 16], 'molecule': [12], 'termed': [13], 'amyloid': [15, 31], 'protein': [17, 25, 78], '(APP).': [18], 'When': [19], 'released': [20], 'cell,': [23], 'these': [24, 59, 138], 'may': [27, 169], 'accumulate': [28], 'extracellular': [30], 'plaques': [32, 131, 168], 'and': [33, 38, 62, 85, 152, 158], 'consequently': [34], 'hasten': [35], 'onset': [37], 'progression': [39], 'of': [40, 51, 58, 70, 88, 111, 137, 146], "Alzheimer's": [41], 'disease': [42], '(AD).': [43], 'β-Amyloid': [44], 'are': [46, 64, 96], 'generated': [47], 'through': [48], 'action': [50], 'specific': [52], 'proteases': [53], 'within': [54, 75], 'cell.': [56], 'Two': [57], 'enzymes,': [60], 'β-': [61, 103], 'γ-secretase,': [63], 'particularly': [65], 'important': [66], 'formation': [69], 'Aβ': [71, 90, 113, 147, 164], 'as': [72], 'they': [73], 'cleave': [74], 'APP': [77], 'to': [79, 82, 125, 129, 149], 'give': [80], 'rise': [81], 'N-terminal': [84], 'C-terminal': [86], 'ends': [87], 'fragment,': [91], 'respectively.': [92], 'Consequently,': [93], 'many': [94], 'researchers': [95], 'investigating': [97], 'therapeutic': [98, 118], 'approaches': [99, 139], 'that': [100, 120, 132, 144, 162], 'inhibit': [101], 'either': [102], 'or': [104], 'γ-secretase': [105], 'activity,': [106], 'with': [107], 'ultimate': [109], 'goal': [110], 'limiting': [112, 163], 'production.': [114], 'An': [115], 'alternative': [116], 'AD': [117, 157], 'approach': [119], 'is': [121, 124], 'being': [122], 'investigated': [123], 'employ': [126], 'anti-Aβ': [127], 'antibodies': [128], 'dissolve': [130], 'have': [133], 'already': [134], 'formed.': [135], 'Both': [136], 'focus': [140], 'on': [141], 'possibility': [143], 'accrual': [145], 'leads': [148], 'neuronal': [150], 'degeneration': [151], 'cognitive': [153], 'impairment': [154], 'characterised': [155], 'by': [156], 'test': [159], 'hypothesis': [161], 'deposition': [165], 'neuritic': [167], 'be': [170], 'an': [171], 'effective': [172], 'treatment': [173], 'for': [174], 'AD.': [175]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2144460602', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}], 'updated_date': '2024-08-15T10:38:49.196359', 'created_date': '2016-06-24'}